{"schema_version":"secwatch.filing_event.v1","accession":"0001161697-25-000142","form_type":"8-K","ticker":"KRMD","cik":"0000704440","company_name":"KORU Medical Systems, Inc.","filed_at":"2025-04-07T23:59:59+00:00","discovered_at":"2026-05-14T18:02:51.057568+00:00","generated_at":"2026-05-23T20:26:51.061214+00:00","sec_items":["5.02","7.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.45,"calibrated_materiality_score":0.45,"confidence":"high","headline":"KORU Medical CCO resigns; FY2025 revenue guidance reiterated at $38-39M","bullets":["Kenneth Miller resigned as Chief Commercial Officer effective April 3, 2025, to become CEO at a non-competing firm.","Rob Cannon (VP of Sales, North America) will lead Core commercial operations until a permanent CCO is named.","Company retained an executive search firm to find a new CCO.","KORU Medical reaffirmed FY2025 revenue guidance of $38.0-$39.0 million, unchanged from March 12 call."],"urls":{"canonical":"https://secwatch.observer/filing/0001161697-25-000142","json":"https://secwatch.observer/filing/0001161697-25-000142.json","markdown":"https://secwatch.observer/filing/0001161697-25-000142.md","text":"https://secwatch.observer/filing/0001161697-25-000142.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/704440/000116169725000142/0001161697-25-000142-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/704440/000116169725000142/form_8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-23T20:26:51.061214+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"4f14e4b6d0","claim":"Kenneth Miller resigned as Chief Commercial Officer at KORU Medical Systems, Inc..","evidence_excerpt":"On April 3, 2025, Kenneth Miller resigned his employment and position as Chief Commercial Officer of KORU Medical Systems, Inc. (the “Company”), effective immediately, to pursue a Chief Executive Officer role at an organization that does not compete with the Company.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/704440/000116169725000142/0001161697-25-000142-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Chief Commercial Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}